Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults

被引:57
|
作者
Erickson, Melissa L. [1 ]
Malin, Steven K. [2 ]
Wang, Zeneng [3 ]
Brown, J. Mark [3 ]
Hazen, Stanley L. [3 ]
Kirwan, John P. [1 ]
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Integrat Physiol & Mol Med Lab, Baton Rouge, LA 70808 USA
[2] Univ Virginia, Dept Kinesiol, Charlottesville, VA 22903 USA
[3] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
trimethylamine N-oxide; obesity; caloric restriction; cardiovascular disease risk factors; gut microbiome; exercise; lifestyle intervention; GUT MICROBIOTA; PROATHEROGENIC METABOLITE; INSULIN-RESISTANCE; MORTALITY RISK; EXERCISE; PHOSPHATIDYLCHOLINE; CHOLINE; METAANALYSIS; CONTRIBUTES; DISEASE;
D O I
10.3390/nu11010179
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Accumulating evidence linking trimethylamine N-oxide (TMAO) to cardiovascular disease (CVD) risk has prompted interest in developing therapeutic strategies to reduce its production. We compared two lifestyle intervention approaches: hypocaloric versus eucaloric diet, combined with exercise, on TMAO levels in relation to CVD risk factors. Sixteen obese adults (66.1 +/- 4.4 years, BMI (body mass index): 35.9 +/- 5.3 kg/m(2), fasting glucose: 106 +/- 16 mg/dL, 2-h PPG (postprandial glucose): 168 +/- 37 mg/dL) were randomly assigned to 12 weeks of exercise (5 days/week, 80-85% HRmax (maximal heart rate)) plus either a hypocaloric (HYPO) (-500 kcal) or a eucaloric (EU) diet. Outcomes included plasma TMAO, glucose metabolism (oral glucose tolerance test (OGTT) and euglycemic-hyperinsulinemic clamps for glucose disposal rates (GDR)), exercise capacity (VO2max, maximal oxygen consumption), abdominal adiposity (computed tomography scans), cholesterol, and triglycerides. Results showed that body composition (body weight, subcutaneous adiposity), insulin sensitivity, VO2max, and cholesterol all improved (p < 0.05). HYPO decreased the percentage change in TMAO compared to an increase after EU (HYPO: -31 +/- 0.4% vs. EU: 32 +/- 0.6%, p = 0.04). Absolute TMAO levels were not impacted (HYPO: p = 0.09 or EU: p = 0.53 group). The change in TMAO after intervention was inversely correlated with baseline visceral adipose tissue (r = -0.63, p = 0.009) and GDR (r = 0.58, p = 0.002). A hypocaloric diet and exercise approach appears to be effective in reducing TMAO. Larger trials are needed to support this observation.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease
    Zeisel, Steven H.
    Warrier, Manya
    ANNUAL REVIEW OF NUTRITION, VOL 37, 2017, 37 : 157 - 181
  • [22] Plasma trimethylamine N-oxide (TMAO): associations with cognition, neuroimaging, and dementia
    Yaqub, Amber
    Vojinovic, Dina
    Vernooij, Meike W.
    Slagboom, P. Eline
    Ghanbari, Mohsen
    Beekman, Marian
    van der Grond, Jeroen
    Hankemeier, Thomas
    van Duijn, Cornelia M.
    Ikram, M. Arfan
    Ahmad, Shahzad
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [23] Microbiome, trimethylamine N-oxide, and CmssMark cardiometabolic disease
    Tang, W. H. Wilson
    Hazen, Stanley L.
    TRANSLATIONAL RESEARCH, 2017, 179 : 108 - 115
  • [24] Association of Trimethylamine N-Oxide and Related Metabolites in Plasma and Incident Type 2 Diabetes The Cardiovascular Health Study
    Lemaitre, Rozenn N.
    Jensen, Paul N.
    Wang, Zeneng
    Fretts, Amanda M.
    McKnight, Barbara
    Nemet, Ina
    Biggs, Mary L.
    Sotoodehnia, Nona
    de Oliveira Otto, Marcia C.
    Psaty, Bruce M.
    Siscovick, David S.
    Hazen, Stanley L.
    Mozaffarian, Dariush
    JAMA NETWORK OPEN, 2021, 4 (08)
  • [25] Plasma trimethylamine N-oxide is associated with vulnerable plaque characteristics in CAD patients as assessed by optical coherence tomography
    Liu, Xinxin
    Xie, Zulong
    Sun, Meng
    Wang, Xuedong
    Li, Ji
    Cui, Jinjin
    Zhang, Fengyun
    Yina, Li
    Huang, Dan
    Hou, Jingbo
    Tian, Jinwei
    Yu, Bo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 265 : 18 - 23
  • [26] Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults
    Lee, Yujin
    Nemet, Ina
    Wang, Zeneng
    Lai, Heidi T. M.
    Otto, Marcia C. de Oliveira
    Lemaitre, Rozenn N.
    Fretts, Amanda M.
    Sotoodehnia, Nona
    Budoff, Matthew
    DiDonato, Joseph A.
    McKnight, Barbara
    Tang, W. H. Wilson
    Psaty, Bruce M.
    Siscovick, David S.
    Hazen, Stanley L.
    Mozaffarian, Dariush
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (17):
  • [27] Trimethylamine N-Oxide as a Potential Biomarker for Cardiovascular Disease: Its Association with Dietary Sources of Trimethylamine N-Oxide and Microbiota
    Karaagac, Yasemin
    EURASIAN JOURNAL OF MEDICINE, 2023, 55 : S21 - S26
  • [28] Association of Trimethylamine N-Oxide and Metabolites With Mortality in Older Adults
    Fretts, Amanda M.
    Hazen, Stanley L.
    Jensen, Paul
    Budoff, Matthew
    Sitlani, Colleen M.
    Wang, Meng
    Otto, Marcia C. de Oliveira
    DiDonato, Joseph A.
    Lee, Yujin
    Psaty, Bruce M.
    Siscovick, David S.
    Sotoodehnia, Nona
    Tang, W. H. Wilson
    Lai, Heidi
    Lemaitre, Rozenn N.
    Mozaffarian, Dariush
    JAMA NETWORK OPEN, 2022, 5 (05) : E2213242
  • [29] Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis
    Jang, Jae Woong
    Capaldi, Emma
    Smith, Tracy
    Verma, Priyanka
    Varga, John
    Ho, Karen J.
    MOLECULAR MEDICINE, 2024, 30 (01)
  • [30] Unraveling interindividual variation of trimethylamine N-oxide and its precursors at the population level
    Andreu-Sanchez, Sergio
    Ahmad, Shahzad
    Kurilshikov, Alexander
    Beekman, Marian
    Ghanbari, Mohsen
    van Faassen, Martijn
    van den Munckhof, Inge C. L.
    Steur, Marinka
    Harms, Amy
    Hankemeier, Thomas
    Ikram, M. Arfan
    Kavousi, Maryam
    Voortman, Trudy
    Kraaij, Robert
    Netea, Mihai G.
    Rutten, Joost H. W.
    Riksen, Niels P.
    Zhernakova, Alexandra
    Kuipers, Folkert
    Slagboom, P. Eline
    van Duijn, Cornelia M.
    Fu, Jingyuan
    Vojinovic, Dina
    IMETA, 2024, 3 (03):